Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Changes in Beneficial Ownership · 4

Cellebrite DI Ltd.

CLBTNASDAQEQUITYCurrent

Changes in Beneficial Ownership

Filed Oct 19, 2026Accepted Oct 19, 2026, 6:56 AM EDTFiling CIK 1854587Accession 0001628280-26-066202
Share

Structured filing — 4

wk-form4_1792407368.xml

Open full document ↗

Filing details

Report period
2026-10-16
Issuer
Cellebrite DI Ltd.
Issuer CIK
0001854587
Trading symbol
CLBT

Reporting owner 1

Name
Barter David
Reporting owner CIK
0001706672
Relationship
Officer
Officer title
Chief Financial Officer
Address
94 SHLOMO SHMELZER ROAD, PETAH TIKVA, ISRAEL, L3, 4970602

Non-derivative transactions

Non-derivative transactions · 1 reported row
SecurityTransaction dateCodeAmountA / DPrice (USD)Owned afterOwnership
Ordinary shares, par value NIS 0.000012026-10-16S · Form 412,134[F1]D11.2139[F2]322,085D
Table key
S · Form 4
Sale on the market or privately
D
Direct

Footnotes

F1
The shares reported as disposed herein were granted on July 7, 2025, in the form of restricted stock units ("RSUs"). The disposition of shares is associated with tax obligations of the reporting person associated with the vesting of the RSUs.↩ 1
F2
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.07 to $11.45, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.↩ 1

Signature 1

Signed
/s/Roei Gamadi, as attorney-in-fact for: David Barter
Date
2026-10-19

Filed exhibits

Company context

Cellebrite’s (Nasdaq: CLBT) mission is to protect communities, nations and businesses as a global leader in digital investigative and intelligence solutions. More than 7,000 global law enforcement agencies, defense and intelligence organizations and enterprises trust Cellebrite’s AI-powered software portfolio to make forensically sound digital data more accessible and actionable. Cellebrite technology allows customers to accelerate nearly 3 million legally sanctioned investigations annually, enhance sovereign security, elevate operational efficacy and efficiency and enable advanced mobile research and application security. Available via cloud, on-premises and hybrid deployments, Cellebrite’s technology enables its customers around the globe to advance their missions, elevate public safety and safeguard data privacy. To learn more, visit us at www.cellebrite.com and https://investors.cellebrite.com and find us on social media @Cellebrite.

Current securities

Historical securities (1)

Recent company filings

  1. 144 filingOct 7, 2026
  2. 4 filingSep 28, 2026
  3. 6-K filingSep 24, 2026
  4. 4 filingSep 17, 2026
  5. 4 filingSep 17, 2026

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.